Neopeltolide (Figure 1) has demonstrated cytotoxic activity
against several cancer lines, including P388 murine leukemia,
A-549 human lung adenocarcinoma, and NCI-ADR-RES
human ovarian sarcoma, with their respective IC50 values
of 0.56, 1.2, and 5.1 nM.2 Recent efforts by Kozmin and
co-workers have suggested that the mode of action of
neopeltolide may involve inhibition of mitochondrial ATP
synthesis with cytochrome bc1 complex as the primary
cellular target.6 A related biological activity of leuscandrolide
A offers circumstantial support that their inherent activity is
primarily associated with their common oxazole carbamate
side chain.
Scheme 1. Retrosynthetic Analysis
able (R)-4-(methoxycarbonyl)-3-methylbutanoic acid10 8 with
borane dimethylsulfide complex. These conditions yielded
a mixture of alcohol 9 and lactone 10 in 92:8 ratio, which
were sequentially treated under Weinreb amidation11 and
Dess-Martin oxidation12 to produce amide-aldehyde 4 in
good yields. This compound represents an interesting syn-
thetic intermediate due to its dual electrophilic sites; however,
it exhibits an appreciable difference in reactivity. By exploit-
ing the more electrophilic aldehyde functionality, asymmetric
allylation should set the C7 stereochemistry necessary for
the neopeltolide macrolactone. Upon screening a variety of
allylation methods, the transformation to homoallylic alcohol
11 was found most effective with Soderquist’s chiral
bicyclodecane-allylborane reagent 5.13a Under modified
reaction conditions, which included an introduction of a
stoichiometric amount of BF3•OEt2, homoallylic alcohol 11
was readily produced in 60%.13b This external Lewis acid
was presumably necessary to sequester the much stronger
Lewis basic Weinreb amide functionality. Conversion of 11
to the corresponding benzyloxymethyl (BOM) ether 12,
necessary for the ether transfer, then proceeded in 92% yield
(Scheme 2).
Figure 1. Neopeltolide and Leucascandrolide A.
Biosynthetically, the C5 side chain is likely incorporated
by a post-PKS process. As post-PKS genes develop late in
the evolutionary history of the producing organism,7 we are
particularly interested in the structural significance of this
oxazole-containing side chain and the inherent activity of
the polyketide core. From the seven published total syntheses
of neopeltolide, only Panek’s route directly accessed the
natural stereochemistry of the neopeltolide macrolactone.4a
Alternatively, the rest involved the production of the C5
epimer followed by stereochemical inversion upon installa-
tion of the oxazole carbamate side chain by the method of
Mitsunobu.4b,5,6
Scheme 2. Synthesis of C4-C11 Segment
We envisioned an assembly of four simple fragments 4-7
for the construction of macrolide 3 (Scheme 1), with ethyl
propiolate 7 serving as a lynchpin for the macrolactonization.
The present total synthesis will be highlighted by the
utilization of our ether transfer methodology,8 which directs
the stereochemistry embedded within the tetrahydropyran
ring.9 More importantly, we have successfully implemented
a strategy that minimizes protecting group manipulation in
a unique fashion, a common and unavoidable practice in
polyketide syntheses. The result is a remarkably efficient,
14-step (longest linear sequence, 15 total steps) synthesis of
the neopeltolide core which will enable full biological
profiling.
Our synthesis then continued with an installation of the
C12-C16 segment by utilizing ꢀ-hydroxylsulfide 6.
The concise synthesis to neopeltolide macrolactone 3
began with chemoselective reduction of commercially avail-
(10) Commercially available from Aldrich or readily accessible in large
scale from enzymatic resolution of dimethyl-3-methylglutarate with porcine
liver esterase: Lam, L. K. P.; Hui, R. A. H. F.; Jones, J. B. J. Org. Chem.
1986, 51, 2047–50.
(7) Young, J.; Taylor, R. E. Nat. Prod. Rep. 2008, 25, 651–655.
(8) Liu, K.; Taylor, R. E.; Kartika, R. Org. Lett. 2006, 8, 5393–5395.
(9) Utilizations of electrophile-induced ether transfer in oxacycle
syntheses: (a) Kartika, R.; Taylor, R. E. Heterocycles 2007, 74, 447–459.
(b) Kartika, R.; Taylor, R. E. Angew. Chem., Int. Ed. 2007, 46, 6874-6877;
Angew. Chem. 2007, 119, 6998-7001. (c) Kartika, R.; Frein, J. D.; Taylor,
R. E. J. Org. Chem. 2008, 73, 5592–5594.
(11) Nahm, S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815–3818.
(12) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155–4156.
(13) (a) Burgos, C. H.; Canales, E.; Matos, K.; Soderquist, J. A. J. Am.
Chem. Soc. 2005, 127, 8044–8049. (b) The minor diastereomer C7(R) was
separable by chromatography and isolated in 6% yield.
5048
Org. Lett., Vol. 10, No. 21, 2008